Advanced search
Start date
Betweenand

Pan-retinal photocoagulation with or without intravitreal Ranibizumab in high risk proliferative diabetic retinopathy

Grant number: 09/01036-3
Support type:Regular Research Grants
Duration: June 01, 2010 - November 30, 2010
Field of knowledge:Health Sciences - Medicine
Principal researcher:Rodrigo Jorge
Grantee:Rodrigo Jorge
Home Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
MESSIAS, ANDRE; RAMOS FILHO, JOSE AFONSO; MESSIAS, KATHARINA; ALMEIDA, FELIPE P. P.; COSTA, ROGERIO A.; SCOTT, INGRID U.; GEKELER, FLORIAN; JORGE, RODRIGO. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. DOCUMENTA OPHTHALMOLOGICA, v. 124, n. 3, p. 225-236, JUN 2012. Web of Science Citations: 11.
FILHO, JOSE A. R.; MESSIAS, ANDRE; ALMEIDA, FELIPE P. P.; RIBEIRO, JEFFERSON A. S.; COSTA, ROGERIO A.; SCOTT, INGRID U.; JORGE, RODRIGO. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. ACTA OPHTHALMOLOGICA, v. 89, n. 7, p. E567-E572, NOV 2011. Web of Science Citations: 27.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.